The Placenta as a Source of Human Material for Neuronal Repair

Area of Science:

• Regenerative Medicine
• Neuroscience
• Biomaterials Science

Background:

• Mesenchymal stem cells (MSCs) show promise for neural tissue repair, but an optimal source is lacking.
• The therapeutic effects of MSCs involve both cell plasticity and secreted biomolecules like extracellular vesicles (EVs) and extracellular matrix (ECM).
• Placenta-derived MSCs (P-MSCs) are an abundant and accessible source but remain understudied for neuroregeneration.

Purpose of the Study:

• To review the existing literature on the neuroregenerative potential of P-MSC-derived biomaterials.
• To highlight P-MSCs as a valuable, yet untapped, source for developing novel regenerative therapies for neural tissues.
• To advocate for further research into P-MSC-derived biomaterials for clinical applications.

Main Methods:

• Literature review of studies investigating P-MSC-derived biomaterials and their effects on neural tissue.
• Analysis of the mechanisms underlying the neuroregenerative properties of MSC-secreted EVs and ECM.
• Synthesis of current knowledge on P-MSC applications in neural repair.

Main Results:

• Evidence suggests P-MSC-derived biomaterials possess neuroregenerative capabilities.
• Secreted factors from MSCs, including EVs and ECM, contribute significantly to trophic effects.
• P-MSCs represent a readily available and potent source for neural regenerative strategies.

Conclusions:

• Placenta-derived MSCs and their biomaterials hold significant, underexplored potential for neural tissue repair and regeneration.
• Further investigation into P-MSC-derived biomaterials is crucial for advancing human regenerative therapies.
• Exploiting P-MSCs could lead to innovative treatments for neurological disorders and injuries.